Drug intelligence / Profile preview

DNF-10

Development stage: Unknown
Lead developer: Fytexia
Modality: Small Molecules, Peptides
Administration: Oral

Overview

DNF-10 is a multi-ingredient dietary supplement combination consisting of L-carnitine tartrate, dihydrocapsiate, and protein yeast hydrolysate, developed for weight management and the treatment of obesity. The formulation utilizes a multi-pathway approach to weight loss: protein yeast hydrolysate (derived from *Saccharomyces cerevisiae*) promotes satiety by modulating appetite-regulating hormones such as ghrelin and cholecystokinin; dihydrocapsiate, a non-pungent capsinoid, stimulates energy expenditure through the activation of TRPV1 receptors and thermogenesis; and L-carnitine tartrate supports fatty acid metabolism by facilitating the transport of long-chain fatty acids into the mitochondria for beta-oxidation. The product has been evaluated in clinical trials to assess its impact on body composition, energy intake, and metabolic rate in overweight individuals.

Brand names: DNF-10DNF10DNF 10
Other names: l-carnitine tartrate + dihydrocapsiate + protein yeast hydrolysateDNF-10 combinationDNF10 combinationDNF 10 combination

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)GHRL (Ghrelin)SLC7A1 (Cationic amino acid transporter 1)

Beyond the preview

Go deeper on DNF-10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNF-10.

Explore the full profile